findmyKOL
Clinical trialNCT04248868CompletedPhase 3Interventional

tPA by Endovascular Administration for the Treatment of Submassive PE Using CDT for the Reduction of Thrombus Burden

SponsorThrombolex, Inc.Enrollment109Pulmonary Embolism
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To demonstrate the efficacy and safety of the Bashir™ Endovascular Catheter for the administration of pharmaco-mechanical catheter directed therapy using low dose r-tPA for the treatment of acute submassive pulmonary embolism.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

19 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucla

    Los Angeles, California, United States

  • Miami Cardiac & Vascular Institute

    Miami, Florida, United States

  • Advent Health Orlando

    Orlando, Florida, United States

  • Emory

    Atlanta, Georgia, United States

  • Piedmont Heart Institute

    Atlanta, Georgia, United States

  • Loyola University Chicago

    Maywood, Illinois, United States

  • Ascension St. Vincent

    Indianapolis, Indiana, United States

  • Ascension St. John Hospital

    Detroit, Michigan, United States

  • Beaumont Hospital, Royal Oak

    Royal Oak, Michigan, United States

  • University of Minnesota

    Minneapolis, Minnesota, United States

  • St. Joseph'S Hospital

    Liverpool, New York, United States

  • Nyu Langone

    New York, New York, United States

  • Nc Heart

    Raleigh, North Carolina, United States

  • Mt Carmel

    Columbus, Ohio, United States

  • Upmc Hamot

    Erie, Pennsylvania, United States

  • Temple University Hospital

    Philadelphia, Pennsylvania, United States

  • Upmc Heart and Vascular Institute

    Pittsburgh, Pennsylvania, United States

  • Tennova Heart - Turkey Creek

    Knoxville, Tennessee, United States

  • Camc

    Charleston, West Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Alteplase →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
23 Jun 2020
Primary completion
22 Jun 2022
Completion
23 Jun 2022
Last update posted
20 Apr 2023
Registered enrollment
109
Registry id
NCT04248868
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.